533 related articles for article (PubMed ID: 28272204)
1. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH
Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204
[TBL] [Abstract][Full Text] [Related]
2. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
[TBL] [Abstract][Full Text] [Related]
5. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
Liu X; Wang W; Meng Q; Zhang F; Hu K
Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725
[TBL] [Abstract][Full Text] [Related]
6. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
[TBL] [Abstract][Full Text] [Related]
7. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
[TBL] [Abstract][Full Text] [Related]
8. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
[TBL] [Abstract][Full Text] [Related]
9. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
10. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.
Beriwal S; Gan GN; Heron DE; Selvaraj RN; Kim H; Lalonde R; Kelley JL; Edwards RP
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):166-71. PubMed ID: 17321070
[TBL] [Abstract][Full Text] [Related]
11. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
12. Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
Lee J; Lin JB; Chang CL; Sun FJ; Wu MH; Jan YT; Chen YJ
Gynecol Oncol; 2018 Feb; 148(2):291-298. PubMed ID: 29269219
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
14. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
[TBL] [Abstract][Full Text] [Related]
16. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic extended-field irradiation for locally advanced cervical cancer.
Li H; Wang S; Liu Y; Wang T; Jin S; Liu Z
Gynecol Oncol; 2022 Sep; 166(3):606-613. PubMed ID: 35868881
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
Jouglar E; Thomas L; de la Rochefordière A; Noël G; Le Blanc-Onfroy M; Delpon G; Campion L; Mahé MA
Cancer Radiother; 2016 Dec; 20(8):794-800. PubMed ID: 28270323
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.
Du XL; Sheng XG; Jiang T; Yu H; Yan YF; Gao R; Lu CH; Li QS
Croat Med J; 2010 Jun; 51(3):229-36. PubMed ID: 20564766
[TBL] [Abstract][Full Text] [Related]
20. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
